Escherichia Coli
New Escherichia coli study findings have been reported from R.J.F. Brando et al
Published in Vaccine Weekly, October 8th, 2008
According to recent research from Buenos Aires, Argentina, "Enterohaemorrhagic Escherichia coli (EHEC) O157:H7 infections are considered a public health problem in both developed and developing countries because of their increasing incidence and the severity of clinical presentation. Approximately 10% of infected patients develop complications such as haemolytic uraemic syndrome (HUS) characterized by acute renal failure, thrombocytopenia and haemolytic anaemia."
"The precise sequence of events leading to HUS is still understood incompletely. Because of the lack of a reproducible small animal model for EHEC infections, in vivo studies examining EHEC-host early...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2008-10-08)
More Articles from Vaccine Weekly
- Bird Flu
Research Shows How AHCC(R) May Help Fight Flu and Other Infectious Agents - Cancer Gene Therapy
Studies in the area of cancer gene therapy reported from P. Yu and co-researchers - Chickenpox
Research from Y. Higashimoto and co-authors provides new data about chickenpox - Dengue Fever
Research from K. Raviprakash and co-authors in the area of dengue fever published - Dengue Fever
Research from World Health Organization in the area of dengue fever described - HIV/AIDS
New HIV/AIDS study results from University of Amsterdam described - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
